Product Information
CEFTRIAXONE 2 GM VIAL is a generic product labeled by Hospira Inc., priced at $2.7000 per EA under NDC 00409733520. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on May 9, 2005. Its Orange Book therapeutic-equivalence code is AP.
Strength
2 g/1
Manufacturer
Hospira Inc.NDC
00409733520
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/19/2026
Active Ingredients
CEFTRIAXONE SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA065169FDA Approved
5/9/2005
TE Code
AP
On Market Since
5/9/2005
Pharmacological Classes
Price Statistics
The NADAC for CEFTRIAXONE 2 GM VIAL has been published 123 times since Apr 17, 2024, and over the history we have for it it has declined 9.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.7000 per EA |
|---|---|
| All-time high | $3.0835 (Sep 11, 2024) |
| All-time low | $2.2684 (Oct 22, 2025) |
| 52-week high | $2.7000 |
| 52-week low | $2.2684 |
| Median price | $2.5582 |
| Average price | $2.6238 |
| Largest weekly change | -11.8% (May 22, 2024) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CEFTRIAXONE 2 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFTRIAXONE 2 GM VIAL, manufactured by Hospira Inc., is $2.7000 per EA (NDC 00409733520), effective Aug 19, 2026.
How has the price of CEFTRIAXONE 2 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFTRIAXONE 2 GM VIAL has declined 9.3%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for CEFTRIAXONE 2 GM VIAL?
Since Apr 17, 2024, the NADAC for CEFTRIAXONE 2 GM VIAL has ranged from a low of $2.2684 (Oct 22, 2025) to a high of $3.0835 (Sep 11, 2024), with a median of $2.5582 per EA.
Are there cheaper alternatives to CEFTRIAXONE 2 GM VIAL?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFTRIAXONE 2 GM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFTRIAXONE 2 GM VIAL?
CEFTRIAXONE 2 GM VIAL (NDC 00409733520) is labeled by Hospira Inc., and CMS classifies it as a generic product.